Timothy Smokoff - 17 Aug 2026 Form 4 Insider Report for VIEMED HEALTHCARE, INC. (VMD)

Reporting relationship: Director
Issuer ticker: VMD
Reported as of: 17 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 Aug 2026, 16:30:18 UTC
Prior SEC filing: 26 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Jesse Bergeron, Attorney-in-Fact

Key filing fact

Timothy Smokoff filed Form 4 for VIEMED HEALTHCARE, INC. (VMD) on 19 Aug 2026.

Key facts

This page summarizes Timothy Smokoff's Form 4 filing for VIEMED HEALTHCARE, INC. (VMD).
7 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 19 Aug 2026, 16:30.

Change

Previous filing in this sequence was filed on 26 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001782064 Primary reporting owner

Smokoff Timothy

Relationship: Director
Address: 625 E. KALISTE SALOOM RD., LAFAYETTE
Signature: /s/ Jesse Bergeron, Attorney-in-Fact
Signature date: 19 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VMD transaction

Common Shares

Options Exercise

Transaction value
Shares: +15,029
Change %: +20%
Price
Shares after: 90,547
Date: 19 Aug 2026
Ownership: Direct
Footnotes: F1

VMD transaction

Common Shares

Options Exercise

Transaction value
Shares: +3,757
Change %: +4.1%
Price
Shares after: 94,304
Date: 19 Aug 2026
Ownership: Direct
Footnotes: F2

VMD transaction

Common Shares

Disposed to Issuer

Transaction value
Shares: -3,757
Change %: -4%
Price: $8.94^*
Shares after: 90,547
Date: 19 Aug 2026
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VMD transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -15,029
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 19 Aug 2026
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 15,029
Exercise price
Footnotes: F1, F4

VMD transaction Derivative

Phantom Share Units

Options Exercise

Transaction value
Shares: -3,757
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 19 Aug 2026
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 3,757
Exercise price
Footnotes: F2, F5

VMD transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares: +12,174
Change %
Price: $0.000000^*
Shares after: 12,174
Date: 17 Aug 2026
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 12,174
Exercise price
Footnotes: F1, F6

VMD transaction Derivative

Phantom Share Units

Award

Transaction value
Shares: +3,043
Change %
Price: $0.000000^*
Shares after: 3,043
Date: 17 Aug 2026
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 3,043
Exercise price
Footnotes: F7, F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.

Footnote F2

Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.

Footnote F3

Per share value is based on the market closing price of the common shares for August 19, 2026.

Footnote F4

On August 19, 2025, the reporting person was granted Restricted Stock Units which vest on August 19, 2026.

Footnote F5

On August 19, 2025, the reporting person was granted Phantom Share Units which vest on August 19, 2026.

Footnote F6

Restricted Stock Units (RSUs) granted to reporting person on August 17, 2026, which vest on the first anniversary of the grant date.

Footnote F7

Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.

Footnote F8

Represents an award granted on August 17, 2026 under the Issuer's Phantom Share Plan which vests on the first anniversary of the grant date.